AbbVie reports Q1 adjusted EPS $2.46, consensus $2.46

Reports Q1 revenue $12.23B, consensus $12.17B. "This year is off to an excellent start, with first-quarter revenues and EPS ahead of our expectations, driven by strong commercial execution across all areas of our diversified portfolio," said Richard Gonzalez, chairman and CEO, AbbVie. "These balanced results give us confidence to increase our full-year guidance and we see numerous opportunities for key assets to drive compelling long-term growth."